Annual Total Debt
$860.20 M
-$545.60 M-38.81%
31 December 2023
Summary:
Emergent BioSolutions annual total debt is currently $860.20 million, with the most recent change of -$545.60 million (-38.81%) on 31 December 2023. During the last 3 years, it has fallen by -$14.60 million (-1.67%). EBS annual total debt is now -38.81% below its all-time high of $1.41 billion, reached on 31 December 2022.EBS Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$662.60 M
-$199.60 M-23.15%
30 September 2024
Summary:
Emergent BioSolutions quarterly total debt is currently $662.60 million, with the most recent change of -$199.60 million (-23.15%) on 30 September 2024. Over the past year, it has dropped by -$199.20 million (-23.11%). EBS quarterly total debt is now -52.87% below its all-time high of $1.41 billion, reached on 31 December 2022.EBS Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -38.8% | -23.1% |
3 y3 years | -1.7% | -21.9% |
5 y5 years | +8.3% | -19.5% |
EBS Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -38.8% | +2.3% | -52.9% | at low |
5 y | 5 years | -38.8% | +8.3% | -52.9% | at low |
alltime | all time | -38.8% | -52.9% |
Emergent BioSolutions Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $662.60 M(-23.2%) |
June 2024 | - | $862.20 M(-4.8%) |
Mar 2024 | - | $905.90 M(+5.3%) |
Dec 2023 | $860.20 M(-38.8%) | $860.20 M(-0.2%) |
Sept 2023 | - | $861.80 M(-4.6%) |
June 2023 | - | $903.20 M(-35.4%) |
Mar 2023 | - | $1.40 B(-0.5%) |
Dec 2022 | $1.41 B(+67.2%) | $1.41 B(+33.5%) |
Sept 2022 | - | $1.05 B(+27.6%) |
June 2022 | - | $825.20 M(-0.9%) |
Mar 2022 | - | $833.10 M(-0.9%) |
Dec 2021 | $841.00 M(-3.9%) | $841.00 M(-0.9%) |
Sept 2021 | - | $848.90 M(-0.6%) |
June 2021 | - | $854.00 M(-0.6%) |
Mar 2021 | - | $859.10 M(-1.8%) |
Dec 2020 | $874.80 M(+7.8%) | $874.80 M(-0.5%) |
Sept 2020 | - | $879.40 M(+11.7%) |
June 2020 | - | $787.20 M(-0.3%) |
Mar 2020 | - | $789.20 M(-2.7%) |
Dec 2019 | $811.30 M(+2.1%) | $811.30 M(-1.5%) |
Sept 2019 | - | $823.40 M(-2.0%) |
June 2019 | - | $840.50 M(+13.2%) |
Mar 2019 | - | $742.50 M(-6.6%) |
Dec 2018 | $794.60 M(+5785.9%) | $794.60 M(+5788.1%) |
Sept 2018 | - | $13.49 M(+0.1%) |
June 2018 | - | $13.48 M(+0.1%) |
Mar 2018 | - | $13.47 M(-0.2%) |
Dec 2017 | $13.50 M(-95.0%) | $13.50 M(-94.6%) |
Sept 2017 | - | $248.99 M(+0.1%) |
June 2017 | - | $248.69 M(+0.1%) |
Mar 2017 | - | $248.39 M(-7.3%) |
Dec 2016 | $268.09 M(+8.6%) | $268.09 M(+0.1%) |
Sept 2016 | - | $267.79 M(+8.2%) |
June 2016 | - | $247.39 M(+0.1%) |
Mar 2016 | - | $247.19 M(+0.1%) |
Dec 2015 | $246.89 M(-1.6%) | $246.89 M(-2.4%) |
Sept 2015 | - | $253.00 M(0.0%) |
June 2015 | - | $253.00 M(+0.8%) |
Mar 2015 | - | $251.00 M(0.0%) |
Dec 2014 | $251.00 M(+304.8%) | $251.00 M(0.0%) |
Sept 2014 | - | $251.00 M(0.0%) |
June 2014 | - | $251.00 M(0.0%) |
Mar 2014 | - | $251.00 M(+304.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2013 | $62.00 M(-1.2%) | $62.00 M(+4.3%) |
Sept 2013 | - | $59.42 M(-1.8%) |
June 2013 | - | $60.54 M(-1.8%) |
Mar 2013 | - | $61.66 M(-1.8%) |
Dec 2012 | $62.77 M(+5.6%) | $62.77 M(-0.4%) |
Sept 2012 | - | $63.01 M(+1.3%) |
June 2012 | - | $62.20 M(+2.2%) |
Mar 2012 | - | $60.87 M(+2.4%) |
Dec 2011 | $59.45 M(+25.4%) | $59.45 M(+10.5%) |
Sept 2011 | - | $53.79 M(+36.9%) |
June 2011 | - | $39.30 M(-15.6%) |
Mar 2011 | - | $46.58 M(-1.8%) |
Dec 2010 | $47.43 M(-27.8%) | $47.43 M(-1.7%) |
Sept 2010 | - | $48.26 M(-1.7%) |
June 2010 | - | $49.10 M(-24.4%) |
Mar 2010 | - | $64.96 M(-1.2%) |
Dec 2009 | $65.72 M(+14.9%) | $65.72 M(+66.0%) |
Sept 2009 | - | $39.59 M(-28.7%) |
June 2009 | - | $55.56 M(-1.7%) |
Mar 2009 | - | $56.52 M(-1.2%) |
Dec 2008 | $57.18 M(-1.3%) | $57.18 M(-2.1%) |
Sept 2008 | - | $58.39 M(-1.6%) |
June 2008 | - | $59.31 M(-1.5%) |
Mar 2008 | - | $60.23 M(+4.0%) |
Dec 2007 | $57.93 M(+35.5%) | $57.93 M(+23.3%) |
Sept 2007 | - | $46.97 M(+44.0%) |
June 2007 | - | $32.62 M(-2.3%) |
Mar 2007 | - | $33.38 M(-21.9%) |
Dec 2006 | $42.77 M(+259.1%) | $42.77 M(+17.3%) |
Sept 2006 | - | $36.47 M(>+9900.0%) |
June 2006 | - | $0.00(0.0%) |
Mar 2006 | - | $0.00(-100.0%) |
Dec 2005 | $11.91 M(-7.4%) | $11.91 M(>+9900.0%) |
Sept 2005 | - | $0.00(0.0%) |
June 2005 | - | $0.00(0.0%) |
Mar 2005 | - | $0.00(-100.0%) |
Dec 2004 | $12.87 M(>+9900.0%) | $12.87 M(>+9900.0%) |
Sept 2004 | - | $0.00(0.0%) |
June 2004 | - | $0.00(0.0%) |
Mar 2004 | - | $0.00 |
Dec 2003 | $0.00(0.0%) | - |
Dec 2002 | $0.00(0.0%) | - |
Dec 2001 | $0.00 | - |
FAQ
- What is Emergent BioSolutions annual total debt?
- What is the all time high annual total debt for Emergent BioSolutions?
- What is Emergent BioSolutions annual total debt year-on-year change?
- What is Emergent BioSolutions quarterly total debt?
- What is the all time high quarterly total debt for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly total debt year-on-year change?
What is Emergent BioSolutions annual total debt?
The current annual total debt of EBS is $860.20 M
What is the all time high annual total debt for Emergent BioSolutions?
Emergent BioSolutions all-time high annual total debt is $1.41 B
What is Emergent BioSolutions annual total debt year-on-year change?
Over the past year, EBS annual total debt has changed by -$545.60 M (-38.81%)
What is Emergent BioSolutions quarterly total debt?
The current quarterly total debt of EBS is $662.60 M
What is the all time high quarterly total debt for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly total debt is $1.41 B
What is Emergent BioSolutions quarterly total debt year-on-year change?
Over the past year, EBS quarterly total debt has changed by -$199.20 M (-23.11%)